HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease.

AbstractBACKGROUND AND AIMS:
Non-O blood type (BT) is a risk factor for thromboses, which has been attributed to its effects on von Willebrand factor (VWF)/factor VIII (FVIII) levels. Although high VWF/FVIII may be risk factors for portal vein thrombosis (PVT) in patients with advanced chronic liver disease (ACLD), the impact of BT on PVT is unknown. We aimed to assess (I) whether non-O-BT is a risk factor for PVT and (II) whether non-O-BT impacts VWF/factor VIII in patients with ACLD.
METHODS:
Retrospective analysis comprising two cohorts: (I) "US" including all adult liver transplantations in the US in the MELD era and (II) "Vienna" comprising patients with a hepatic venous pressure gradient (HVPG) ≥6 mmHg.
RESULTS:
(I) The "US cohort" included 84 947 patients (non-O: 55.43%). The prevalence of PVT at the time of listing (4.37% vs 4.56%; P = .1762) and at liver transplantation (9.56% vs 9.33%; P = .2546) was similar in patients with O- and non-O-BT. (II) 411 patients were included in the "Vienna cohort" (non-O: 64%). Mean HVPG was 18(9) mmHg and 90% had an HVPG ≥10 mmHg. Patients with non-O-BT had slightly increased VWF levels (318(164)% vs 309(176)%; P = .048; increase of 23.8%-23.9% in adjusted analyses), but this difference was driven by patients with less advanced disease. However, non-O-BT explained only 1% of the variation in VWF and had no effect on FVIII.
CONCLUSIONS:
Although non-O-BT impacts VWF in patients with early stage ACLD, its contribution to VWF variation is considerably smaller than in the general population. Moreover, non-O-BT had no impact on FVIII. These findings may explain the absence of an association between non-O-BT and PVT in patients with advanced cirrhosis.
AuthorsBernhard Scheiner, Patrick G Northup, Anselm B Gruber, Georg Semmler, Gerda Leitner, Peter Quehenberger, Johannes Thaler, Cihan Ay, Michael Trauner, Thomas Reiberger, Ton Lisman, Mattias Mandorfer
JournalLiver international : official journal of the International Association for the Study of the Liver (Liver Int) Vol. 40 Issue 6 Pg. 1415-1426 (06 2020) ISSN: 1478-3231 [Electronic] United States
PMID32052552 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Copyright©2020 The Authors. Liver International published by John Wiley & Sons Ltd.
Chemical References
  • ABO Blood-Group System
  • von Willebrand Factor
  • Factor VIII
Topics
  • ABO Blood-Group System
  • Adult
  • Factor VIII
  • Humans
  • Liver Cirrhosis (complications)
  • Portal Vein (pathology)
  • Prevalence
  • Retrospective Studies
  • Venous Thrombosis
  • von Willebrand Factor

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: